Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lowe

Showing results (221-230 of 243) with videos related to

Pageof 25
Sort By:
Therapeutic Drug Monitoring|September 28, 2007
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimenSelwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, et al.
The Journal of Arthroplasty|March 19, 2025
The Selective Use of Acetabular Screws in Routine Primary Total Hip Arthroplasty Is Noninferior to Habitual Screw UseGerard A Sheridan, Lyndon Y H Lowe, Andrew J Hughes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral TherapyN Chantal Peltenburg, Mathie P G Leers, Jaap A Bakker, et al.
The Lancet Regional Health. Europe|January 6, 2026
Risk of new HIV diagnosis by intersecting migration, socioeconomic, and mental health vulnerabilities in the Netherlands: a nationwide analysis of the ATHENA cohort and Statistics Netherlands registry dataVita W Jongen, Anders Boyd, Patrizia Carrieri, et al.
HIV Clinical Trials|January 2, 2007
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrationsSelwyn H Lowe, Annemarie M J Wensing, Jacqueline A H Droste, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2018
Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activityN Chantal Peltenburg, Jörgen Bierau, Jolanda A Schippers, et al.
Plos One|January 13, 2018
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIVN Chantal Peltenburg, Jörgen Bierau, Jaap A Bakker, et al.
British Journal of Cancer|June 24, 2024
Social determinants of health inequalities in early phase clinical trials in Northern EnglandS Rae, S Shaya, E Taylor, et al.
Proceedings. Biological Sciences|November 25, 2016
Vive la résistance: genome-wide selection against introduced alleles in invasive hybrid zonesRyan P Kovach, Brian K Hand, Paul A Hohenlohe, et al.
HIV Clinical Trials|November 25, 2005
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES)S H Lowe, A M J Wensing, E A M Hassink, et al.
Pageof 25

Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
Therapeutic Drug Monitoring|September 28, 2007
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimenSelwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, et al.
The Journal of Arthroplasty|March 19, 2025
The Selective Use of Acetabular Screws in Routine Primary Total Hip Arthroplasty Is Noninferior to Habitual Screw UseGerard A Sheridan, Lyndon Y H Lowe, Andrew J Hughes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral TherapyN Chantal Peltenburg, Mathie P G Leers, Jaap A Bakker, et al.
The Lancet Regional Health. Europe|January 6, 2026
Risk of new HIV diagnosis by intersecting migration, socioeconomic, and mental health vulnerabilities in the Netherlands: a nationwide analysis of the ATHENA cohort and Statistics Netherlands registry dataVita W Jongen, Anders Boyd, Patrizia Carrieri, et al.
HIV Clinical Trials|January 2, 2007
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrationsSelwyn H Lowe, Annemarie M J Wensing, Jacqueline A H Droste, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2018
Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activityN Chantal Peltenburg, Jörgen Bierau, Jolanda A Schippers, et al.
Plos One|January 13, 2018
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIVN Chantal Peltenburg, Jörgen Bierau, Jaap A Bakker, et al.
British Journal of Cancer|June 24, 2024
Social determinants of health inequalities in early phase clinical trials in Northern EnglandS Rae, S Shaya, E Taylor, et al.
Proceedings. Biological Sciences|November 25, 2016
Vive la résistance: genome-wide selection against introduced alleles in invasive hybrid zonesRyan P Kovach, Brian K Hand, Paul A Hohenlohe, et al.
HIV Clinical Trials|November 25, 2005
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES)S H Lowe, A M J Wensing, E A M Hassink, et al.
Pageof 25